2021 Naloxone Market Market | Analysis, Recent Trends and Regional Growth Forecast by 2028
Naloxone is an opioid overdose reversal medicine used to treat morphine and heroin overdoses. Naloxone is an opioid antagonist that is classified as a prescription drug by the US Food and Drug Administration (FDA). However, some countries, such as Italy and Australia, have reclassified it as an over-the-counter (OTC) medication. Naloxone Market products come in a variety of strengths. 0.4 mg/ml, 1 mg/ml, 0.4 mg/0.4ml, 4 mg/0.1ml, and more doses of naloxone are currently available. Naloxone is given through a variety of methods, including intranasal, intramuscular/subcutaneous, and intravenous. The most recent medicine on the market is intranasal naloxone, which can be administered by anyone (non-medical professional). Intravenous products, on the other hand, are mostly administered by medical professionals who have been appropriately trained.
The global Naloxone Market is predicted to expand because to the frequent launches and approvals of innovative naloxone medicines. Over the projection period, increasing releases and approvals of innovative naloxone products by various regulatory authorities are expected to be a prominent factor boosting market expansion. The US Food and Drug Administration (FDA) approved Adapt Pharma Inc.'s NARCAN Nasal Spray 2 mg formulation for the emergency treatment of known or suspected opioid overdose in January 2017.
Naloxone hydrochloride injection USP, 0.4 mg/mL, packaged in 1 mL single-dose vials was introduced by Mylan N.V. in 2016. It is therapeutically comparable to Hospira Inc.'s naloxone hydrochloride injection of 0.4 mg/mL. The European Medicines Agency (EMA) approved Mundipharma International Limited's medication (intranasal naloxone 1.8 mg) for use in emergency opioid overdose reversal in September 2017. The global Naloxone Market was worth US$ 310.2 million in 2017, and it is predicted to grow at a CAGR of 11.4% from 2018 to 2026.
Increasing Demand for Treatment Drugs
As the number of people dying from opioid overdoses rises, demand for naloxone products for emergency treatment is likely to rise, boosting the global Naloxone Market. According to data released by the United States Department of Health and Human Services (HHS) in 2016, approximately 11.5 million Americans misuse prescription medicines, while 948,000 people use heroin. According to the National Institute on Drug Abuse, about 115 persons die in the United States every day as a result of opioid overdosing in 2018. According to the same source, opioid overdoses in the United States climbed by 30% in 52 locations across 45 states between July 2016 and September 2017.
Comments
Post a Comment